Skip to content
Recall Observatory FDA recall evidence

Device product

HardyCHROM MRSA,REF; G307, LOT: 447694, A selective and differential chromogenic medium for the qualitative direct detection of nasal colonization by methicillin-resistant Staphylococcus aureus (MRSA). Not intended to diagnose infection of guide therapy. Further testing required for susceptibility or typing. Container Type: 15 x 100mm monoplate Packaged: 10 plates/sleeve STORAGE: 2-8 degree C on receipt, LIGHT SENSITIVE IVD UDI: (01)08165760201400 (10)447694 (17)191206

Z-2298-2020

November 14, 2019

Class II

Product summary

Firm
Hardy Diagnostics
Event
Event 85412
Status
Terminated
Classification
Class II
Quantity
3,580 ea (358 kits, pack of 10 in each)
Official record key
device-enforcement:Z-2298-2020

Official wording

Reason: False Positive results due to the MSSA (methicillin-susceptible) strain Staphylococcus aureus (ATCC 29213) breakthrough when this strain should have been inhibited.

Code information: Catalogue no.: G307, Lot number 447694 HDx, UDI # 00816576020140

Distribution pattern: U.S. Distribution in the states of WI, CA, WA, IA, MT, UT, AZ, WY, KS, MO, OR, TX, VI, including PR and Guam. OUS: British Virgin Islands, Kenya,

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    False Positive results due to the MSSA (methicillin-susceptible) strain Staphylococcus aureus (ATCC 29213) breakthrough when this strain should have been inhibited.